Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply.

Bond, Ashley

Editorial: metabolomic biomarkers for colorectal adenocarcinoma and in the differentiation between irritable bowel syndrome and ulcerative colitis in clinical remission - confounded by the gut microbiome? Authors' reply. [electronic resource] - Alimentary pharmacology & therapeutics 04 2019 - 1087-1088 p. digital

Publication Type: Editorial; Comment

1365-2036

10.1111/apt.15196 doi


Adenocarcinoma
Biomarkers
Colitis, Ulcerative
Colorectal Neoplasms
Feces
Gastrointestinal Microbiome
Humans
Irritable Bowel Syndrome
Volatile Organic Compounds